The Alliance for Biopharmaceutical Competitiveness and Innovation is a trade association representing biopharmaceutical companies. It lobbies Congress mainly on tax rules, especially corporate and international taxation and negotiations under the OECD Pillar 1 and Pillar 2 frameworks that affect how global income is taxed. It hired The Washington Tax & Public Policy Group and reported about $1.5 million in lobbying across five filings.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
GREGORY NICKERSON
The latest disclosures for this client.
THE WASHINGTON TAX & PUBLIC POLICY GROUP
Q3THE WASHINGTON TAX & PUBLIC POLICY GROUP
Q2The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
THE WASHINGTON TAX & PUBLIC POLICY GROUP
mr JAMES MAX PEDROTTI
THE WASHINGTON TAX & PUBLIC POLICY GROUP
ZACHARY AUSTIN PRICE
THE WASHINGTON TAX & PUBLIC POLICY GROUP
THE WASHINGTON TAX & PUBLIC POLICY GROUP
Q1THE WASHINGTON TAX & PUBLIC POLICY GROUP
Q4THE WASHINGTON TAX & PUBLIC POLICY GROUP
Q3THE WASHINGTON TAX & PUBLIC POLICY GROUP
Q2THE WASHINGTON TAX & PUBLIC POLICY GROUP
Q1